Leukaemia Care Logo
donate

Menu

08088 010 444

Help and Resources

Here, you'll find lots of resources to help you whether you're a patient, carer, fundraiser or medical professional.

Know your rights toolkit

We have produced a number of bitesize pieces of information to help you understand the options that are available to you, access further information and make informed decisions.

Information Booklets

Learn more about your diagnosis in our information booklets.

Leukaemia Matters magazine

Leukaemia Matters is a patient magazine published four times a year. You can subscribe to Leukaemia Matters for free by going to the request a resource page.

Fundraising Resources

Get your fundraising off to a flying start with our selection of downloadable materials.

Our reports

Our reports are based on the findings from our surveys and are written with the patient in mind.

Request a Resource

To order printed information, please select the number of each resource you require, and fill in your contact details. Unfortunately, we are unable to send printed information overseas.

Mindfulness

Mindfulness is a psychological, self-help therapy involving being aware moment-to-moment of your subjective consciousness that can be developed using meditational practices.

Read More

Take a Moment to Catch Up

View our latest news and blog artcicles

August 10th

Go spotty for Blood Cancer Awareness Month

Could you take on an event for Blood Cancer Awareness Month this September? We need you to show your support and get involved with our #SpotLeukaemia campaign. Check out these fundraising ideas for some spotty inspiration....

August 9th

Inotuzumab ozogamicin recommended for acute lymphoblastic leukaemia (ALL) patients

NICE have today recommended the use of inotuzumab ozogamicin to treat relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukaemia (ALL) in adults....

August 9th

NHS England removes restrictions that were preventing relapsed CLL patients from gaining access to ibrutinib

Today (9th August 2018) NHS England removes restrictions that had been preventing relapsed chronic lymphocytic leukaemia patients from getting treatment with ibrutinib a NICE approved therapy....